Laboratory Assessment of Direct Oral Anticoagulants

Jonathan Douxfils, Robert C Gosselin

Résultats de recherche: Contribution à un journal/une revueArticle de revue

Résumé

Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable pharmacokinetic and food impact of warfarin, episodic monitoring is required. Since the early 2000s, direct oral anticoagulants (DOACs) entered into clinical trials as a potential alternative strategy to oral vitamin K antagonists for long-term anticoagulation. As these drugs have predictable pharmacokinetics and pharmacodynamics, there was no requirement for episodic or routine monitoring. However, shortly after their introduction into clinical use, it became apparent that certain emergent or acute situations may require some capacity to measure these drugs, especially in a bleeding patient with DOAC exposure. The scramble for literature and data to support or suggest laboratory methods which can rapidly and accurately quantify or estimate DOAC concentration soon began. This review describes the literature to date, and recommendations for laboratories to provide tests that will assure either the presence/absence of DOAC or the capacity to quantify DOAC using rapid methods that could be implemented on most clinical laboratory instruments.

langueAnglais
Pages277-290
Nombre de pages14
journalSeminars in thrombosis and hemostasis
Volume43
Numéro3
Les DOIs
étatPublié - 2017
Modification externeOui

Empreinte digitale

Anticoagulants
Warfarin
Vitamin K
Pharmacokinetics
Pharmaceutical Preparations
Clinical Trials
Hemorrhage
Food
Therapeutics

mots-clés

    Citer ceci

    Douxfils, Jonathan ; Gosselin, Robert C. / Laboratory Assessment of Direct Oral Anticoagulants. Dans: Seminars in thrombosis and hemostasis. 2017 ; Vol 43, Numéro 3. p. 277-290.
    @article{53be747a291e4ec1a5f82594f24b6e56,
    title = "Laboratory Assessment of Direct Oral Anticoagulants",
    abstract = "Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable pharmacokinetic and food impact of warfarin, episodic monitoring is required. Since the early 2000s, direct oral anticoagulants (DOACs) entered into clinical trials as a potential alternative strategy to oral vitamin K antagonists for long-term anticoagulation. As these drugs have predictable pharmacokinetics and pharmacodynamics, there was no requirement for episodic or routine monitoring. However, shortly after their introduction into clinical use, it became apparent that certain emergent or acute situations may require some capacity to measure these drugs, especially in a bleeding patient with DOAC exposure. The scramble for literature and data to support or suggest laboratory methods which can rapidly and accurately quantify or estimate DOAC concentration soon began. This review describes the literature to date, and recommendations for laboratories to provide tests that will assure either the presence/absence of DOAC or the capacity to quantify DOAC using rapid methods that could be implemented on most clinical laboratory instruments.",
    keywords = "Journal Article",
    author = "Jonathan Douxfils and Gosselin, {Robert C}",
    note = "Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.",
    year = "2017",
    doi = "10.1055/s-0036-1597296",
    language = "English",
    volume = "43",
    pages = "277--290",
    journal = "Seminars in thrombosis and hemostasis",
    issn = "0094-6176",
    publisher = "Thieme Medical Publishers",
    number = "3",

    }

    Laboratory Assessment of Direct Oral Anticoagulants. / Douxfils, Jonathan; Gosselin, Robert C.

    Dans: Seminars in thrombosis and hemostasis, Vol 43, Numéro 3, 2017, p. 277-290.

    Résultats de recherche: Contribution à un journal/une revueArticle de revue

    TY - JOUR

    T1 - Laboratory Assessment of Direct Oral Anticoagulants

    AU - Douxfils, Jonathan

    AU - Gosselin, Robert C

    N1 - Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

    PY - 2017

    Y1 - 2017

    N2 - Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable pharmacokinetic and food impact of warfarin, episodic monitoring is required. Since the early 2000s, direct oral anticoagulants (DOACs) entered into clinical trials as a potential alternative strategy to oral vitamin K antagonists for long-term anticoagulation. As these drugs have predictable pharmacokinetics and pharmacodynamics, there was no requirement for episodic or routine monitoring. However, shortly after their introduction into clinical use, it became apparent that certain emergent or acute situations may require some capacity to measure these drugs, especially in a bleeding patient with DOAC exposure. The scramble for literature and data to support or suggest laboratory methods which can rapidly and accurately quantify or estimate DOAC concentration soon began. This review describes the literature to date, and recommendations for laboratories to provide tests that will assure either the presence/absence of DOAC or the capacity to quantify DOAC using rapid methods that could be implemented on most clinical laboratory instruments.

    AB - Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable pharmacokinetic and food impact of warfarin, episodic monitoring is required. Since the early 2000s, direct oral anticoagulants (DOACs) entered into clinical trials as a potential alternative strategy to oral vitamin K antagonists for long-term anticoagulation. As these drugs have predictable pharmacokinetics and pharmacodynamics, there was no requirement for episodic or routine monitoring. However, shortly after their introduction into clinical use, it became apparent that certain emergent or acute situations may require some capacity to measure these drugs, especially in a bleeding patient with DOAC exposure. The scramble for literature and data to support or suggest laboratory methods which can rapidly and accurately quantify or estimate DOAC concentration soon began. This review describes the literature to date, and recommendations for laboratories to provide tests that will assure either the presence/absence of DOAC or the capacity to quantify DOAC using rapid methods that could be implemented on most clinical laboratory instruments.

    KW - Journal Article

    U2 - 10.1055/s-0036-1597296

    DO - 10.1055/s-0036-1597296

    M3 - Review article

    VL - 43

    SP - 277

    EP - 290

    JO - Seminars in thrombosis and hemostasis

    T2 - Seminars in thrombosis and hemostasis

    JF - Seminars in thrombosis and hemostasis

    SN - 0094-6176

    IS - 3

    ER -